GGrantIndex
Sort

78,016 grants matching breast cancer

Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment

$1,044,547
Xiao Han · Clarix Imaging Corporation · R44 · FY2019 · CA

MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)

$1,044,393
Harold L Moses · Vanderbilt University · U54 · FY2012 · CA

Signaling Pathways in Stages of Tumorigenesis

$1,043,958
Gail E Sonenshein · Boston University Medical Campus · P01 · FY2008 · ES

Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution

$1,043,889
Michel Mikhail · Trevarx Biomedical, Inc. · R42 · FY2023 · CA

Determining the Fate of Transmembrane Proteins

$1,043,590
Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Testing scalable communication modalities for returning breast cancer genetic research results to African American women

$1,043,560
Catharine Wang · Boston University Medical Campus · R01 · FY2021 · MD

CANCER AND LEUKEMIA GROUP B CCOP RESEARCH BASE

$1,043,494
University Of Chicago · U10 · FY2000 · CA

UChicago Interdisciplinary Cancer Health Disparities SPORE

$1,043,400
Olufunmilayo I Olopade · University Of Chicago · P20 · FY2019 · CA

Determining the Fate of Transmembrane Proteins

$1,043,252
Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

WAVE3 IS A BIOMAKER FOR BREAST CANCER PROGRESSION AND METASTASIS

$1,043,114
The Cleveland Clinic Foundation · · FY2008 · Department of the Army

ATUSA: World's First Wearable and Automated 3D Breast Ultrasound System with AI

$1,043,109
Shadi Saberi · Isono Health, Inc. · R44 · FY2024 · CA

The Role of Cripto in the Pathogenesis of Breast and Colon Cancer

$1,042,793
David Salomon · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Mechanisms of the Hormonal Prevention of Breast Cancer

$1,042,720
Baylor College Of Medicine · P01 · FY2002 · CA

Delaware/Christiana Care CCOP

$1,042,698
Stephen S. Grubbs · Christiana Care Health Services, Inc. · U10 · FY2008 · CA

Vaccine and immunotherapy strategies for cancer and viruses causing cancer

$1,042,696
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA

Physiological and pathological functions of E3 ubiquitin ligases Smurfs

$1,042,668
Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Search for the Structural Basis of Biomacromolecular Function and Activity

$1,042,358
Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Discovery and verification of novel biomarkers of colorectal cancer recurrence

$1,042,128
Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA

Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer

$1,041,837
Brett Stewart Carver · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA

Development of a Molecular Assay to Diagnose Malignant Pleural Effusions

$1,041,709
Mark A Nelson · Precision Epigenomics, Inc. · R44 · FY2025 · CA

Late Effects of Treatment in Wilms Tumor Survivors and Offspring

$1,041,309
Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA

TEXAS CANCER GENETICS CONSORTIUM

$1,041,093
University Of Texas Md Anderson Can Ctr · U24 · FY2000 · CA

Risk Factors for Breast Cancer in Younger Nurses

$1,041,084
Walter C. Willett · Harvard School Of Public Health · R01 · FY2017 · CA

ASIAN AMERICAN NETWORK FOR CANCER AWARENESS RESEARCH & TRAINING

$1,041,004
Moon S Chen · University Of California At Davis · U01 · FY2007 · CA

A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women

$1,040,468
David J. Margolis · University Of Pennsylvania · U01 · FY2021 · AR